Osseointegrated Implants in the Scenario of Osteonecrosis Occurrence with the use of Bisphosphonates: A Descriptive Review of Clinical Studies
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | MedNEXT Journal of Medical and Health Sciences |
Texto Completo: | https://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/33 |
Resumo: | The most common bone disorder found by implant dentists is osteoporosis, which is a systemic skeletal disorder associated with aging, which is characterized by loss of bone mass, making bones fragile and more susceptible to fractures. The World Health Organization has defined osteoporosis as a bone mineral density level greater than 2.5 standard deviations below the mean of young normal women. After 60 years of age, a third of the population have this disorder, it occurs twice as often in women than in men. It is estimated that 1.3 million fractures and 133,000 all hip fractures occur every year as a result of osteoporosis. The aim of this study was to discuss aspects of the pharmacological action of Bisphosphonates (BP) and their influence on the bone tissue when associated with treatment with dental implants. There are several types of treatments which prevent or prevent the progression of osteoporosis. So, BP, such as alendronate, are inhibitors of bone resorption. Act as controlling the development of osteoporosis by increasing the process of bone density and decrease its reabsorption, often acting as supporting the process of osseointegration of dental implants. |
id |
FACERES-1_e712b44c894c434bea01ac03a0437854 |
---|---|
oai_identifier_str |
oai:ojs2.mednext.zotarellifilhoscientificworks.com:article/33 |
network_acronym_str |
FACERES-1 |
network_name_str |
MedNEXT Journal of Medical and Health Sciences |
repository_id_str |
|
spelling |
Osseointegrated Implants in the Scenario of Osteonecrosis Occurrence with the use of Bisphosphonates: A Descriptive Review of Clinical StudiesOsteoporosisOsteonecrosisBone resorptionOsseointegrationDental implantComplications The most common bone disorder found by implant dentists is osteoporosis, which is a systemic skeletal disorder associated with aging, which is characterized by loss of bone mass, making bones fragile and more susceptible to fractures. The World Health Organization has defined osteoporosis as a bone mineral density level greater than 2.5 standard deviations below the mean of young normal women. After 60 years of age, a third of the population have this disorder, it occurs twice as often in women than in men. It is estimated that 1.3 million fractures and 133,000 all hip fractures occur every year as a result of osteoporosis. The aim of this study was to discuss aspects of the pharmacological action of Bisphosphonates (BP) and their influence on the bone tissue when associated with treatment with dental implants. There are several types of treatments which prevent or prevent the progression of osteoporosis. So, BP, such as alendronate, are inhibitors of bone resorption. Act as controlling the development of osteoporosis by increasing the process of bone density and decrease its reabsorption, often acting as supporting the process of osseointegration of dental implants. Faceres2021-03-28info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/otherapplication/pdfhttps://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/3310.34256/mdnt2125MedNEXT Journal of Medical and Health Sciences; Vol. 2 No. 2 (2021): MedNEXT; 27–33MedNEXT Journal of Medical and Health Sciences; v. 2 n. 2 (2021): MedNEXT; 27–332763-5678reponame:MedNEXT Journal of Medical and Health Sciencesinstname:Faculdade de Medicina em São José do Rio Preto (Faceres)instacron:FACERESenghttps://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/33/33Copyright (c) 2021 MedNEXT Journal of Medical and Health Scienceshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessBraga Marcato, Fábio RenatoFerreira de Gois Marcato, Juliana CarolineZotarelli Filho, Idiberto JoséKassis, Elias Naim2021-09-16T14:05:30Zoai:ojs2.mednext.zotarellifilhoscientificworks.com:article/33Revistahttps://mednext.zotarellifilhoscientificworks.com/index.php/mednextPUBhttps://mednext.zotarellifilhoscientificworks.com/index.php/mednext/oaimednextjmhs@zotarellifilhoscientificworks.com2763-56782763-5678opendoar:2021-09-16T14:05:30MedNEXT Journal of Medical and Health Sciences - Faculdade de Medicina em São José do Rio Preto (Faceres)false |
dc.title.none.fl_str_mv |
Osseointegrated Implants in the Scenario of Osteonecrosis Occurrence with the use of Bisphosphonates: A Descriptive Review of Clinical Studies |
title |
Osseointegrated Implants in the Scenario of Osteonecrosis Occurrence with the use of Bisphosphonates: A Descriptive Review of Clinical Studies |
spellingShingle |
Osseointegrated Implants in the Scenario of Osteonecrosis Occurrence with the use of Bisphosphonates: A Descriptive Review of Clinical Studies Braga Marcato, Fábio Renato Osteoporosis Osteonecrosis Bone resorption Osseointegration Dental implant Complications |
title_short |
Osseointegrated Implants in the Scenario of Osteonecrosis Occurrence with the use of Bisphosphonates: A Descriptive Review of Clinical Studies |
title_full |
Osseointegrated Implants in the Scenario of Osteonecrosis Occurrence with the use of Bisphosphonates: A Descriptive Review of Clinical Studies |
title_fullStr |
Osseointegrated Implants in the Scenario of Osteonecrosis Occurrence with the use of Bisphosphonates: A Descriptive Review of Clinical Studies |
title_full_unstemmed |
Osseointegrated Implants in the Scenario of Osteonecrosis Occurrence with the use of Bisphosphonates: A Descriptive Review of Clinical Studies |
title_sort |
Osseointegrated Implants in the Scenario of Osteonecrosis Occurrence with the use of Bisphosphonates: A Descriptive Review of Clinical Studies |
author |
Braga Marcato, Fábio Renato |
author_facet |
Braga Marcato, Fábio Renato Ferreira de Gois Marcato, Juliana Caroline Zotarelli Filho, Idiberto José Kassis, Elias Naim |
author_role |
author |
author2 |
Ferreira de Gois Marcato, Juliana Caroline Zotarelli Filho, Idiberto José Kassis, Elias Naim |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Braga Marcato, Fábio Renato Ferreira de Gois Marcato, Juliana Caroline Zotarelli Filho, Idiberto José Kassis, Elias Naim |
dc.subject.por.fl_str_mv |
Osteoporosis Osteonecrosis Bone resorption Osseointegration Dental implant Complications |
topic |
Osteoporosis Osteonecrosis Bone resorption Osseointegration Dental implant Complications |
description |
The most common bone disorder found by implant dentists is osteoporosis, which is a systemic skeletal disorder associated with aging, which is characterized by loss of bone mass, making bones fragile and more susceptible to fractures. The World Health Organization has defined osteoporosis as a bone mineral density level greater than 2.5 standard deviations below the mean of young normal women. After 60 years of age, a third of the population have this disorder, it occurs twice as often in women than in men. It is estimated that 1.3 million fractures and 133,000 all hip fractures occur every year as a result of osteoporosis. The aim of this study was to discuss aspects of the pharmacological action of Bisphosphonates (BP) and their influence on the bone tissue when associated with treatment with dental implants. There are several types of treatments which prevent or prevent the progression of osteoporosis. So, BP, such as alendronate, are inhibitors of bone resorption. Act as controlling the development of osteoporosis by increasing the process of bone density and decrease its reabsorption, often acting as supporting the process of osseointegration of dental implants. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-03-28 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion info:eu-repo/semantics/other |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/33 10.34256/mdnt2125 |
url |
https://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/33 |
identifier_str_mv |
10.34256/mdnt2125 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/33/33 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2021 MedNEXT Journal of Medical and Health Sciences https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2021 MedNEXT Journal of Medical and Health Sciences https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Faceres |
publisher.none.fl_str_mv |
Faceres |
dc.source.none.fl_str_mv |
MedNEXT Journal of Medical and Health Sciences; Vol. 2 No. 2 (2021): MedNEXT; 27–33 MedNEXT Journal of Medical and Health Sciences; v. 2 n. 2 (2021): MedNEXT; 27–33 2763-5678 reponame:MedNEXT Journal of Medical and Health Sciences instname:Faculdade de Medicina em São José do Rio Preto (Faceres) instacron:FACERES |
instname_str |
Faculdade de Medicina em São José do Rio Preto (Faceres) |
instacron_str |
FACERES |
institution |
FACERES |
reponame_str |
MedNEXT Journal of Medical and Health Sciences |
collection |
MedNEXT Journal of Medical and Health Sciences |
repository.name.fl_str_mv |
MedNEXT Journal of Medical and Health Sciences - Faculdade de Medicina em São José do Rio Preto (Faceres) |
repository.mail.fl_str_mv |
mednextjmhs@zotarellifilhoscientificworks.com |
_version_ |
1796798219138629632 |